Skip to main content
SpringerLink
Log in

Treatment of refractory bipolar depression

  • Clinical Trials Report
  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Suppes T, Mintz J, McElroy SL, et al.: Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenon. Arch Gen Psychiatry 2005, 62:1089–1096.

    Article  PubMed  Google Scholar 

  2. Altshuler LL, Post RM, Black DO, et al.: Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study. J Clin Psychiatry 2006, 67:1551–1560.

    Article  PubMed  Google Scholar 

  3. Altshuler L, Suppes T, Black D, et al.: Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am J Psychiatry 2003, 160:1252–1262.

    Article  PubMed  Google Scholar 

  4. Altshuler LL, Suppes T, Black DO, et al.: Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants. Am J Psychiatry 2006, 163:313–315.

    Article  PubMed  Google Scholar 

  5. Leverich GS, Altshuler LL, Frye MA, et al.: Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry 2006, 163:232–239.

    Article  PubMed  Google Scholar 

  6. Post RM, Altshuler LL, Leverich GS, et al.: Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry 2006, 189:124–131.

    Article  PubMed  CAS  Google Scholar 

  7. Thase ME: Bipolar depression: issues in diagnosis and treatment. Harv Rev Psychiatry 2005, 13:257–271.

    Article  PubMed  Google Scholar 

  8. Sachs GS, Nierenberg AA, Calabrese JR, et al.: Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007, 356:1711–1722.

    Article  PubMed  CAS  Google Scholar 

  9. Frye MA, Ketter TA, Kimbrell TA, et al.: A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000, 20:607–614.

    Article  PubMed  CAS  Google Scholar 

  10. Nierenberg AA, Ostacher MJ, Calabrese JR, et al.: Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry 2006, 163:210–216.

    Article  PubMed  Google Scholar 

  11. Himmelhoch JM, Thase ME, Mallinger AG, Houck P: Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry 1991, 148:910–916.

    PubMed  CAS  Google Scholar 

  12. Thase ME, Mallinger AG, McKnight D, Himmelhoch JM: Treatment of imipramine-resistant recurrent depression, IV: A double-blind crossover study of tranylcypromine for anergic bipolar depression. Am J Psychiatry 1992, 149:195–198.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Michael E. Thase
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thase, M.E. Treatment of refractory bipolar depression. Curr Psychiatry Rep 9, 495–496 (2007). https://doi.org/10.1007/s11920-007-0067-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-007-0067-x

Keywords

Search

Navigation